Skip to main content
Clinical Trials/JPRN-UMIN000052666
JPRN-UMIN000052666
Completed
未知

Effects of consumption of the test food on waist circumference (abdominal circumference) in healthy Japanese: a randomized, placebo-controlled, double-blind, parallel-group comparison study - Effects of consumption of the test food on waist circumference (abdominal circumference) in healthy Japanese

ORTHOMEDICO Inc.0 sites100 target enrollmentDecember 1, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Healthy Japanese
Sponsor
ORTHOMEDICO Inc.
Enrollment
100
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 1, 2023
End Date
April 28, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Individuals (who/whose) 1\. are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2\. have a pacemaker or an implantable cardioverter defibrillator (ICD) 3\. currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, chronic kidney disease, cerebrovascular disorder, rheumatic disease, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4\. are taking "Foods for Specified Health Uses" or "Foods with Functional Claims" 5\. take herb or foods with hypoglycemic effects 6\. are taking medications (including herbal medicines) and supplements 7\. are allergic to medicines and/or the test food related products 8\. notice a weak stomach and may feel discomfort such as convergence in the stomach, particularly when taking beverages containing tannin such as green tea, black tea, or coffee 9\. have irregular lifestyles (such as diet, exercise, and sleep) 10\. weekly average of pure alcohol intake is more than 60 g/day 11\. are pregnant, lactating, or planning to become pregnant during this trial 12\. have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 13\. have donated blood component or 200 mL whole blood within the last one month before the agreement to participate in this trial 14\. have donated 400 mL whole blood within the last three month before the agreement to participate in this trial 15\. are scheduling to have a total of more than 1,200 mL of blood drawn until the end of this study from the 12 months before the date of consent obtained 16\. are judged as ineligible to participate in this study by the physician

Outcomes

Primary Outcomes

Not specified

Similar Trials